"World's smallest neurostimulator" approved in Australia for chronic pain
This article was originally published in Clinica
St Jude Medical's Eon Mini neurostimulator has been approved by the Australian Therapeutic Goods Administration for chronic pain. The matchbox-sized Eon Mini, which the St Paul, Minnesota firm claims is the world's smallest and longest-lasting rechargeable device in its class, will be used to treat chronic pain of the trunk or limbs and pain from failed back surgery. It is typically implanted in a patient's lower back, and connected to electrical leads which are placed near the spinal cord. These deliver electrical pulses to interrupt or mask the pain signal as it travels to the brain. Eon Mini received US FDA approval and was CE marked for sale in Europe in April 2008.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.